These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 6093518)

  • 21. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceftriaxone: increasing the half-life and activity of third generation cephalosporins.
    Steele RW
    Pediatr Infect Dis; 1985; 4(2):188-91. PubMed ID: 3885182
    [No Abstract]   [Full Text] [Related]  

  • 23. Delayed cerebrospinal fluid sterilization, in vitro bactericidal activities, and side effects of selected beta-lactams.
    Dajani AS; Pokowski LH
    Scand J Infect Dis Suppl; 1990; 73():31-42. PubMed ID: 2091255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children.
    Lebel MH; McCracken GH
    Pediatrics; 1989 Feb; 83(2):161-7. PubMed ID: 2913547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of cefotaxime in gram-negative bacterial meningitis. Apropos of 3 developmental forms in neonates and infants].
    Sarlangue J; Megraud F; Nelson JR; Martin C
    Pediatrie; 1984 Dec; 39(8):645-51. PubMed ID: 6100207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging role of cephalosporins in bacterial meningitis.
    Nelson JD
    Am J Med; 1985 Aug; 79(2A):47-51. PubMed ID: 3849260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftriaxone therapy of bacterial meningitis: cerebrospinal fluid concentrations and bactericidal activity after intramuscular injection in children treated with dexamethasone.
    Bradley JS; Farhat C; Stamboulian D; Branchini OG; Debbag R; Compogiannis LS
    Pediatr Infect Dis J; 1994 Aug; 13(8):724-8. PubMed ID: 7970973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of cefotaxime and ceftriaxone alone and in combination with penicillin, ampicillin and piperacillin against neonatal meningitis pathogens.
    Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1985 Sep; 16(3):327-34. PubMed ID: 3932295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment.
    Kanegaye JT; Soliemanzadeh P; Bradley JS
    Pediatrics; 2001 Nov; 108(5):1169-74. PubMed ID: 11694698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serious pediatric infections.
    Kaplan SL
    Am J Med; 1990 Apr; 88(4A):18S-24S. PubMed ID: 2183605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quantitative study of the antibacterial effect of cefotaxime and ceftriaxone during experimental Escherichia coli K1 bacteremia in chickens].
    Labarthe JC; Guillot JF; Mouline C; Bree A
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):664-7. PubMed ID: 2677929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children.
    Frenkel LD
    Pediatrics; 1988 Sep; 82(3 Pt 2):486-91. PubMed ID: 3405685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ceftriaxone (Rocéphine) in major African infectious pathology. Results at the Niamey Hospital (Niger) ].
    Rey JL; Konarjevski R; Madras R; Ousseini A; Félix H
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):513-6. PubMed ID: 6289228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.
    Decazes JM; Ernst JD; Sande MA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):463-7. PubMed ID: 6316841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children.
    Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K
    Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftriaxone in treatment of serious infections. Meningitis.
    Scheld WM
    Hosp Pract (Off Ed); 1991 Sep; 26 Suppl 5():14-9; discussion 54-5. PubMed ID: 1918217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.
    Beskid G; Christenson JG; Cleeland R; DeLorenzo W; Trown PW
    Antimicrob Agents Chemother; 1981 Aug; 20(2):159-67. PubMed ID: 6269487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.